- Home
- VATE vs GNTA Comparison
VATE vs GNTA Comparison
Compare VATE & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VATE
- GNTA
- Stock Information
- Founded
- VATE 1994
- GNTA 2014
- Country
- VATE United States
- GNTA Italy
- Employees
- VATE 4024
- GNTA N/A
- Industry
- VATE Metal Fabrications
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VATE Industrials
- GNTA Health Care
- Exchange
- VATE Nasdaq
- GNTA Nasdaq
- Market Cap
- VATE 82.6M
- GNTA 67.4M
- IPO Year
- VATE 1996
- GNTA 2021
- Fundamental
- Price
- VATE $6.10
- GNTA $5.34
- Analyst Decision
- VATE
- GNTA Strong Buy
- Analyst Count
- VATE 0
- GNTA 1
- Target Price
- VATE N/A
- GNTA $25.00
- AVG Volume (30 Days)
- VATE 50.3K
- GNTA 28.4K
- Earning Date
- VATE 11-06-2024
- GNTA 01-01-0001
- Dividend Yield
- VATE N/A
- GNTA N/A
- EPS Growth
- VATE N/A
- GNTA N/A
- EPS
- VATE N/A
- GNTA N/A
- Revenue
- VATE $1,364,600,000.00
- GNTA N/A
- Revenue This Year
- VATE N/A
- GNTA N/A
- Revenue Next Year
- VATE N/A
- GNTA N/A
- P/E Ratio
- VATE N/A
- GNTA N/A
- Revenue Growth
- VATE N/A
- GNTA N/A
- 52 Week Low
- VATE $3.25
- GNTA $2.20
- 52 Week High
- VATE $14.60
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- VATE 71.67
- GNTA 56.89
- Support Level
- VATE $6.18
- GNTA $4.89
- Resistance Level
- VATE $6.49
- GNTA $6.20
- Average True Range (ATR)
- VATE 0.43
- GNTA 0.70
- MACD
- VATE 0.05
- GNTA -0.06
- Stochastic Oscillator
- VATE 86.72
- GNTA 37.32
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.